Agilent Technologies, Inc. $A Shares Purchased by Swiss National Bank

Swiss National Bank increased its position in Agilent Technologies, Inc. (NYSE:A) by 7.1% in the 1st quarter, Holdings Channel reports. The firm owned 832,000 shares of the medical research company’s stock after buying an additional 55,300 shares during the period. Swiss National Bank’s holdings in Agilent Technologies were worth $94,831,000 as of its most recent filing with the SEC.

A number of other large investors have also recently made changes to their positions in A. Fiduciary Trust Co lifted its stake in Agilent Technologies by 1.6% in the third quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock valued at $633,000 after buying an additional 77 shares during the last quarter. NorthCrest Asset Manangement LLC grew its position in shares of Agilent Technologies by 1.6% during the fourth quarter. NorthCrest Asset Manangement LLC now owns 5,082 shares of the medical research company’s stock worth $726,000 after acquiring an additional 79 shares during the last quarter. Freestone Capital Holdings LLC increased its holdings in shares of Agilent Technologies by 2.0% in the 4th quarter. Freestone Capital Holdings LLC now owns 4,218 shares of the medical research company’s stock valued at $574,000 after acquiring an additional 84 shares during the period. Grove Bank & Trust increased its holdings in shares of Agilent Technologies by 5.5% in the 4th quarter. Grove Bank & Trust now owns 1,758 shares of the medical research company’s stock valued at $239,000 after acquiring an additional 92 shares during the period. Finally, Plan A Wealth LLC raised its position in Agilent Technologies by 3.2% in the 4th quarter. Plan A Wealth LLC now owns 2,959 shares of the medical research company’s stock valued at $403,000 after purchasing an additional 92 shares during the last quarter.

Agilent Technologies Trading Down 0.7%

Shares of Agilent Technologies stock opened at $130.55 on Tuesday. The company has a 50-day moving average of $127.87 and a two-hundred day moving average of $125.49. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $160.27. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. The stock has a market cap of $36.87 billion, a PE ratio of 26.21, a price-to-earnings-growth ratio of 2.34 and a beta of 1.25.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, beating analysts’ consensus estimates of $1.41 by $0.08. The business had revenue of $1.83 billion during the quarter, compared to analysts’ expectations of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The business’s revenue for the quarter was up 10.0% on a year-over-year basis. During the same quarter last year, the business posted $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, research analysts anticipate that Agilent Technologies, Inc. will post 6 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th will be given a dividend of $0.255 per share. The ex-dividend date is Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a yield of 0.8%. Agilent Technologies’s dividend payout ratio (DPR) is 20.48%.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the stock. TD Cowen increased their target price on shares of Agilent Technologies from $147.00 to $155.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Jefferies Financial Group initiated coverage on Agilent Technologies in a research note on Thursday, July 9th. They set a “hold” rating and a $135.00 price objective for the company. Piper Sandler assumed coverage on Agilent Technologies in a research report on Thursday, June 11th. They set a “neutral” rating and a $150.00 price objective for the company. Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. Finally, Bank of America raised Agilent Technologies from a “neutral” rating to a “buy” rating and dropped their target price for the company from $150.00 to $145.00 in a report on Thursday, May 28th. Two research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $159.35.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.